Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12615060rdf:typepubmed:Citationlld:pubmed
pubmed-article:12615060lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C1185740lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C0441587lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C1999177lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:12615060lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:12615060pubmed:issue3lld:pubmed
pubmed-article:12615060pubmed:dateCreated2003-3-4lld:pubmed
pubmed-article:12615060pubmed:abstractTextReportedly, in human immunodeficiency virus type 1 (HIV) vectors, insertion of central polypurine tract (cPPT) increased expression of transgenes for a short period. To test this for a stable condition, we constructed a series of vectors carrying a Neo(r) gene as a stable marker driven by a synthetic thymidine kinase (hTK) promoter. Transduction efficiency was increased in about 2-fold and decreased in about 8-fold by insertion of the reported 178bp and our 282bp cPPTs, respectively. PCR analyses revealed that insertion of 282bp cPPT, but not 178bp cPPT, impaired integration, although it did not deteriorate nuclear transport much. Furthermore, we found that insertion of 282bp cPPT between hTK promoter and an upstream LTR sequence reduced reporter gene activity in about 5-fold. This inhibitory effect of 282bp cPPT may partly account for the observed decrease in transduction efficiency. We suggest that actual effect of cPPT insertion should be examined in each HIV vector.lld:pubmed
pubmed-article:12615060pubmed:languageenglld:pubmed
pubmed-article:12615060pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12615060pubmed:citationSubsetIMlld:pubmed
pubmed-article:12615060pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12615060pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12615060pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12615060pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12615060pubmed:statusMEDLINElld:pubmed
pubmed-article:12615060pubmed:monthMarlld:pubmed
pubmed-article:12615060pubmed:issn0006-291Xlld:pubmed
pubmed-article:12615060pubmed:authorpubmed-author:KitamuraYoshi...lld:pubmed
pubmed-article:12615060pubmed:authorpubmed-author:KobayashiNori...lld:pubmed
pubmed-article:12615060pubmed:authorpubmed-author:AeKeisukeKlld:pubmed
pubmed-article:12615060pubmed:authorpubmed-author:SakumaRyutaRlld:pubmed
pubmed-article:12615060pubmed:issnTypePrintlld:pubmed
pubmed-article:12615060pubmed:day14lld:pubmed
pubmed-article:12615060pubmed:volume302lld:pubmed
pubmed-article:12615060pubmed:ownerNLMlld:pubmed
pubmed-article:12615060pubmed:authorsCompleteYlld:pubmed
pubmed-article:12615060pubmed:pagination489-95lld:pubmed
pubmed-article:12615060pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:meshHeadingpubmed-meshheading:12615060...lld:pubmed
pubmed-article:12615060pubmed:year2003lld:pubmed
pubmed-article:12615060pubmed:articleTitleInhibitory and enhancing effects of insertion of central polypurine tract sequence on gene expression with vectors derived from human immunodeficiency virus type 1.lld:pubmed
pubmed-article:12615060pubmed:affiliationDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.lld:pubmed
pubmed-article:12615060pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12615060pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed